ISIN | CH0102306922 |
---|---|
Valor Number | 10230692 |
Bloomberg Global ID | BBG00162SDV3 |
Fund Name | Schroder Swiss Equity Core Fund A |
Fund Provider |
Schroder Investment Management (Switzerland) AG (LUX & CH)
Zurich/Geneva, Switzerland Web: https://www.schroders.com/en/ch/asset-management/ Phone: +41 (0) 800 844 448 E-Mail: info-sim@schroders.com |
Fund Provider | Schroder Investment Management (Switzerland) AG (LUX & CH) |
Representative in Switzerland | |
Distributor(s) |
Schroder & Co Bank AG Zürich Phone: +41 44 250 11 11 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | Schroder Swiss Equity Core Fund is an open-end fund incorporated in Switzerland. The Fund's objective is to obtain long-term capital growth. The Fund is actively managed and tries to exceeds the performance of Swiss Performance Index (SPI). |
Peculiarities |
Current Price * | 226.25 CHF | 16.04.2025 |
---|---|---|
Previous Price * | 227.29 CHF | 15.04.2025 |
52 Week High * | 255.26 CHF | 03.03.2025 |
52 Week Low * | 212.70 CHF | 09.04.2025 |
NAV * | 226.25 CHF | 16.04.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 17,678,626 | |
Unit/Share Assets *** | 123,702 | |
Trading Information SIX |
YTD Performance | -0.60% |
30.12.2024 - 16.04.2025
30.12.2024 16.04.2025 |
---|---|---|
1 month | -10.34% |
17.03.2025 - 16.04.2025
17.03.2025 16.04.2025 |
3 months | -3.73% |
16.01.2025 - 16.04.2025
16.01.2025 16.04.2025 |
6 months | -5.53% |
16.10.2024 - 16.04.2025
16.10.2024 16.04.2025 |
1 year | +2.94% |
16.04.2024 - 16.04.2025
16.04.2024 16.04.2025 |
2 years | +1.02% |
17.04.2023 - 16.04.2025
17.04.2023 16.04.2025 |
3 years | -3.64% |
19.04.2022 - 16.04.2025
19.04.2022 16.04.2025 |
5 years | +26.05% |
16.04.2020 - 16.04.2025
16.04.2020 16.04.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novartis AG Registered Shares | 13.39% | |
---|---|---|
Nestle SA | 13.04% | |
Roche Holding AG | 12.94% | |
Compagnie Financiere Richemont SA Class A | 5.71% | |
Zurich Insurance Group AG | 5.43% | |
UBS Group AG | 3.31% | |
ABB Ltd | 2.63% | |
Partners Group Holding AG | 2.50% | |
Sandoz Group AG Registered Shares | 2.49% | |
Alcon Inc | 2.17% | |
Last data update | 31.03.2025 |
TER | 1.04% |
---|---|
TER date | 31.12.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.00% |
Ongoing Charges *** | 1.09% |
SRRI ***
|
|
SRRI date *** | 31.03.2025 |